Superstring Capital Management
New York City, New Yorksuperstringcap.com
Overview
Superstring Capital Management is a New York-based investment firm dedicated to the healthcare sector, with a focus on public and private investments in pharmaceutical, biotechnology, medtech, and healthcare services companies globally.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| LakeShore Biopharma Co., Ltd. | Nov 2025 | M&A | Co-investor |
| Sironax | Aug 2022 | Series B | Co-investor |
| Jiangsu Synthgene Biotechnology Co., Ltd. | Nov 2021 | Series B | Co-investor |
| Singleron Biotechnologies | Nov 2021 | Series B | Co-investor |
| Shoreline Biosciences | Nov 2021 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
